Recursion Pharmaceuticals, Inc. financial data

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Former names
Recursion Pharmaceuticals, LLC (to 12/4/2015)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 491 % +3.34%
Debt-to-equity 37.5 % -14.9%
Return On Equity -76.6 % -19.3%
Return On Assets -55.7 % -25%
Operating Margin -605 % +8.24%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 286M shares +32.3%
Entity Public Float 930M USD -1.16%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 283M shares +31.8%
Weighted Average Number of Shares Outstanding, Diluted 283M shares +31.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 65.2M USD +37.6%
Research and Development Expense 286M USD +32.4%
General and Administrative Expense 131M USD +31.2%
Costs and Expenses 459M USD +27.8%
Operating Income (Loss) -394M USD -26.3%
Nonoperating Income (Expense) 11.2M USD -36.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -383M USD -2.86%
Income Tax Expense (Benefit) -5.2M USD
Net Income (Loss) Attributable to Parent -378M USD -29.1%
Earnings Per Share, Basic -1.56 USD/shares -7.59%
Earnings Per Share, Diluted -1.56 USD/shares -7.59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 428M USD +10.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 42.7M USD +140%
Assets, Current 474M USD +15.5%
Property, Plant and Equipment, Net 84.4M USD -2.13%
Operating Lease, Right-of-Use Asset 47.9M USD +40.6%
Intangible Assets, Net (Excluding Goodwill) 34.1M USD -13.6%
Goodwill 52.1M USD -1.32%
Other Assets, Noncurrent 360K USD +132%
Assets 726M USD +15.2%
Accounts Payable, Current 2.26M USD -47%
Employee-related Liabilities, Current 19.7M USD -11.6%
Accrued Liabilities, Current 40.6M USD +1.99%
Contract with Customer, Liability, Current 49.6M USD +12.7%
Liabilities, Current 109M USD +15.7%
Long-term Debt and Lease Obligation 20.5M USD
Contract with Customer, Liability, Noncurrent 15.7M USD -69.4%
Deferred Income Tax Liabilities, Net 168K USD -91.3%
Operating Lease, Liability, Noncurrent 53.7M USD +21.1%
Other Liabilities, Noncurrent 3M USD
Liabilities 202M USD +4.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.25B USD -43.2%
Stockholders' Equity Attributable to Parent 525M USD +19.8%
Liabilities and Equity 726M USD +15.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -102M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 13.9M USD +623%
Net Cash Provided by (Used in) Investing Activities -6.65M USD -24.6%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 286M shares +32.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -95.3M USD -24.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 436M USD +9.72%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13K USD -7.14%
Deferred Tax Assets, Valuation Allowance 305M USD +82.7%
Deferred Tax Assets, Gross 320M USD +79.2%
Operating Lease, Liability 61.9M USD +24.7%
Depreciation 16.2M USD +8.73%
Payments to Acquire Property, Plant, and Equipment 6.65M USD +28.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -378M USD -29.1%
Lessee, Operating Lease, Liability, to be Paid 79.1M USD +18%
Property, Plant and Equipment, Gross 141M USD +10.8%
Operating Lease, Liability, Current 8.23M USD +53.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.5M USD +51.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.6M USD +45.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.2M USD -0.97%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.9M USD +54%
Deferred Tax Assets, Operating Loss Carryforwards 118M USD +31%
Unrecognized Tax Benefits 5.42M USD +96.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.2M USD +25.1%
Additional Paid in Capital 1.78B USD +35.4%
Amortization of Intangible Assets 14.7M USD +178%
Depreciation, Depletion and Amortization 7.38M USD +97.9%
Deferred Tax Assets, Net of Valuation Allowance 15.6M USD +30.6%
Share-based Payment Arrangement, Expense 64.9M USD +49.6%
Interest Expense 98K USD +63.3%